摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-氯-4-甲基吡啶-2-羧酸 | 324028-95-7

中文名称
6-氯-4-甲基吡啶-2-羧酸
中文别名
6-氯-4-甲基吡啶-2-甲酸;4-甲基-6-氯吡啶-2-甲酸;2-氯-4-甲基吡啶-6-甲酸;6-氯-4-甲基-2-吡啶羧酸
英文名称
6-chloro-4-methylpicolinic acid
英文别名
6-chloro-4-methylpyridine-2-carboxylic acid
6-氯-4-甲基吡啶-2-羧酸化学式
CAS
324028-95-7
化学式
C7H6ClNO2
mdl
MFCD09834827
分子量
171.583
InChiKey
IDIRHQNTRMGBPJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    341.8±37.0 °C(Predicted)
  • 密度:
    1.390±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 海关编码:
    2933399090
  • 危险品运输编号:
    UN 2811
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温

SDS

SDS:0cac82256190f82a1ed9918199f6329c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 6-Chloro-4-methylpyridine-2-carboxylic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 6-Chloro-4-methylpyridine-2-carboxylic acid
CAS number: 324028-95-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6ClNO2
Molecular weight: 171.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (6-Chloro-4-methylpyridine-2-carboxylic acid)

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-氯-4-甲基吡啶-2-羧酸草酰氯N,N-二甲基甲酰胺 作用下, 以 二氯甲烷 为溶剂, 反应 3.0h, 生成 6-Chloro-4-methylpyridine-2-carbonyl chloride
    参考文献:
    名称:
    CXCR4 Receptor Antagonists
    摘要:
    披露了一些对CXCR4受体具有拮抗作用的化合物。
    公开号:
    US20130289020A1
  • 作为产物:
    描述:
    6-氯-4-甲基-2-氰基吡啶盐酸 为溶剂, 以84.5%的产率得到6-氯-4-甲基吡啶-2-羧酸
    参考文献:
    名称:
    N-(phenylsulfonyl)picolinamide derivatives, process for producing the same, and herbicide
    摘要:
    一种除草剂,其活性成分为一种由通式(I)表示的N-(苯基磺酰基)吡啶甲酰胺衍生物,其中X代表卤素、C1-4烷基、C1-4卤代烷基、C1-4烷氧基、C1-4卤代烷氧基、(C1-4烷氧基)羰基、[二(C1-4烷基)氨基]磺酰基、[N-(C1-4烷基)-N-(C1-4烷氧基)氨基]磺酰基、(C1-4烷基氨基)磺酰基、C1-4烷基硫醚、C1-4烷基亚砜基、C1-4烷基磺酰基或硝基;n为0至5的整数;Y代表卤素、C1-4烷基、C1-4卤代烷基、C1-4烷氧基、C1-4卤代烷氧基、C1-4烷基硫醚、C1-4卤代烷基硫醚、氨基、C1-4烷基氨基、二(C1-4烷基)氨基、(C1-4烷氧基)C1-4烷基、(C1-4烷基硫醚)C1-4烷基或硝基;m为0至4的整数。该活性成分通过将取代吡啶甲酸与取代苯磺酰胺在脱水条件下缩合合成,或者在碱性化合物存在下,将取代吡啶甲酸的苯酯与取代苯磺酰胺反应而制备。
    公开号:
    US06610853B1
点击查看最新优质反应信息

文献信息

  • [EN] CD38 INHIBITORS<br/>[FR] INHIBITEURS DE CD38
    申请人:MITOBRIDGE INC
    公开号:WO2021207186A1
    公开(公告)日:2021-10-14
    One embodiment of the invention is a compound represented by Formula I: or a pharmaceutically acceptable salt thereof. The variables in Formula I are defined herein. Compounds of Formula I are CD38 inhibitors, which can be used to treat a disease or condition in a subject that benefits from an increase in NAD+ or to treat a mitochondrial disorder in a subject.
    该发明的一个实施例是由化学式I表示的化合物:或其药用可接受的盐。化学式I中的变量在此处定义。化学式I的化合物是CD38抑制剂,可用于治疗需要增加NAD+的受试者的疾病或病况,或用于治疗受试者的线粒体疾病。
  • [EN] CXCR4 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR CXCR4
    申请人:PROXIMAGEN LTD
    公开号:WO2012049277A1
    公开(公告)日:2012-04-19
    The compounds of formula (I) are antagonists of the CXCR4 receptor Wherein R1 , X, Y and R2 are as defined in the claims.
    式(I)的化合物是CXCR4受体的拮抗剂,其中R1、X、Y和R2如权利要求中所定义。
  • SUBSTITUTED 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRIDINE-3(2H)-ONES AND 2,5,6,7-TETRAHYDRO-3H-PYRROLO[2,1-C][1,2,4]TRIAZOL-3-ONES, AND USE THEREOF
    申请人:BAYER AKTIENGESELLSCHAFT
    公开号:US20190160048A1
    公开(公告)日:2019-05-30
    The present application relates to novel substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-ones and 2,5,6,7-tetrahydro-3H-pyrrolo[2,1-c][1,2,4]triazol-3-ones, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of lung inflammation disorders.
    该申请涉及新颖的取代5,6,7,8-四氢[1,2,4]三唑并[4,3-a]吡啶-3(2H)-酮和2,5,6,7-四氢-3H-吡咯[2,1-c][1,2,4]三唑-3-酮,其制备方法,以及其单独或组合使用用于治疗和/或预防疾病,以及其用于生产用于治疗和/或预防疾病的药物,特别是用于治疗和/或预防肺部炎症性疾病。
  • [EN] PHARMACEUTICAL COMPOUND<br/>[FR] COMPOSÉ PHARMACEUTIQUE
    申请人:IOMET PHARMA LTD
    公开号:WO2017007700A1
    公开(公告)日:2017-01-12
    Provided is a tryptophan-2,3-dioxygenase (TDO) and/or indoleamine-2,3-dioxygenase (IDO) inhibitor compound for use in medicine, which compound comprises the general formula (I) detailed within.
    提供了一种色氨酸-2,3-二氧化酶(TDO)和/或吲哚胺-2,3-二氧化酶(IDO)抑制剂化合物,用于医学用途,该化合物包括详细在其中的一般式(I)。
  • [EN] HETEROARYL AMIDE INHIBITORS OF CD38<br/>[FR] INHIBITEURS AMIDES HÉTÉROARYLES DE CD38
    申请人:NAPA THERAPEUTICS LTD
    公开号:WO2022077034A1
    公开(公告)日:2022-04-14
    Disclosed are heteroaryl amide inhibitors of CD38 and methods of making and using the same in disease and disorder treatment.
    揭示了CD38的杂环酰胺抑制剂及其在疾病和障碍治疗中的制备和使用方法。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-N'-亚硝基尼古丁 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非尼拉朵 非尼拉敏 阿雷地平 阿瑞洛莫 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 锇二(2,2'-联吡啶)氯化物 链黑霉素 链黑菌素 银杏酮盐酸盐 铬二烟酸盐 铝三烟酸盐 铜-缩氨基硫脲络合物 铜(2+)乙酸酯吡啶(1:2:1) 铁5-甲氧基-6-甲基-1-氧代-2-吡啶酮 钾4-氨基-3,6-二氯-2-吡啶羧酸酯 钯,二氯双(3-氯吡啶-κN)-,(SP-4-1)-